Atorvastatin Calcium tablets recalled due to manufacturing practice deviations
Accord Healthcare is recalling 147,736 bottles of Atorvastatin Calcium 40 mg tablets due to manufacturing practice deviations discovered during an FDA inspection.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall initiated following manufacturing practice deviations discovered during regulatory inspection. No reported illnesses or injuries, consistent with risk-of-harm classification where injury has not yet been reported.
Plain-English summary
Accord Healthcare, Inc. is recalling 147,736 bottles of Atorvastatin Calcium Tablets USP 40 mg distributed in the United States, Puerto Rico, and Canada. The affected product is available in two packaging configurations and multiple batch numbers with expiration dates ranging from April 2023 through September 2024.
The recall was initiated following an FDA inspection that identified Current Good Manufacturing Practice (CGMP) deviations at the manufacturing facility. CGMP deviations relate to manufacturing and quality control procedures that ensure drug safety and quality.
Atorvastatin Calcium is a prescription medication. Patients who have been taking this medication and possess tablets from the affected batches should consult their healthcare provider.
Patients should not stop taking their medication without consulting their doctor. Consumers with questions should contact Accord Healthcare, Inc. or speak with their pharmacist or healthcare provider for guidance on alternative options and next steps.
The recalled product
- Product
- ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM)
- Brand
- ATORVASTATIN CALCIUM
- Manufacturer
- Accord Healthcare, Inc.
- Category
- Drug — Prescription Drug
- Hazard
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Batches: a)R2100552
- R2100553
- Exp. Date 4/30/2023
- R2200253
- Exp. Date 2/29/2024
- R2200627
- Exp. Date 4/30/2024
- R2201113
- Exp. Date 6/30/2024
- R2201184
- Exp. Date 8/31/2024
- R2201366
- Exp. Date 9/30/2024
- b) R2200280
- R2200385
- R2200386
- R2200491
- R2200490
- R2200494
- R2200496
UPCs (2)
- 316729046152
- 316729046176
Distribution
Distribution scope not specified by the agency.
Related recalls
Same brand · ATORVASTATIN CALCIUM
- HighBiocon Pharma atorvastatin calcium tablets recalled for failed dissolution specifications
FDA (Drugs) · 2025-04-09
- HighPrescription atorvastatin bottles recalled for containing wrong medication
FDA (Drugs) · 2024-10-09
- ModerateAtorvastatin Calcium Tablets Recalled for Manufacturing Quality Violations
FDA (Drugs) · 2023-05-03
- HighAtorvastatin Calcium 80 mg tablets recalled for manufacturing quality deviations
FDA (Drugs) · 2023-03-08
- ModeratePrescription Drug Recall: Atorvastatin Calcium Tablets for Manufacturing Deviations
FDA (Drugs) · 2023-03-08
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27